A major shift in federal policy threatens to dismantle the booming market for hemp-derived products designed to impair users, as lawmakers have moved to shut down a long-standing legal loophole. The industry, valued in the billions, has relied on a regulatory gap that distinguished hemp-based cannabinoids from their marijuana counterparts, enabling widespread sales of items like edibles and extracts. With Congress now poised to close this exemption, businesses and consumers alike may face significant disruptions in access to these products. The decision could reshape both the legal landscape and the economic future of a rapidly growing sector.
America's multibillion-dollar market for impairing hemp products faces potential elimination after Congress voted to close a loophole in federal law that has allowed it to flourish.
